These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Dastjerdi MH; Saban DR; Okanobo A; Nallasamy N; Sadrai Z; Chauhan SK; Hajrasouliha AR; Dana R Invest Ophthalmol Vis Sci; 2010 May; 51(5):2411-7. PubMed ID: 19892863 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Koenig Y; Bock F; Horn F; Kruse F; Straub K; Cursiefen C Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1375-82. PubMed ID: 19415316 [TBL] [Abstract][Full Text] [Related]
12. Corneal graft surgery combined with subconjunctival bevacizumab (avastin). Symes RJ; Poole TR Cornea; 2010 Jun; 29(6):691-3. PubMed ID: 20458243 [TBL] [Abstract][Full Text] [Related]
13. Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab. Dekaris I; Gabrić N; Drača N; Pauk-Gulić M; Miličić N Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):287-94. PubMed ID: 25398659 [TBL] [Abstract][Full Text] [Related]
14. Ranibizumab injection for corneal neovascularization refractory to bevacizumab treatment. Ahn YJ; Hwang HB; Chung SK Korean J Ophthalmol; 2014 Apr; 28(2):177-80. PubMed ID: 24688262 [TBL] [Abstract][Full Text] [Related]
15. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. Qian CX; Bahar I; Levinger E; Rootman D Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781 [TBL] [Abstract][Full Text] [Related]
16. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization. You IC; Im SK; Lee SH; Yoon KC Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729 [TBL] [Abstract][Full Text] [Related]
18. Topical bevacizumab for corneal neovascularization after penetrating keratoplasty. Saxena S; Kishore P; Pandey S; Khattri M; Kumar D Eur J Ophthalmol; 2009; 19(5):870-2. PubMed ID: 19787612 [TBL] [Abstract][Full Text] [Related]
19. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study. Benayoun Y; Adenis JP; Casse G; Forte R; Robert PY Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391 [TBL] [Abstract][Full Text] [Related]
20. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization. Yeung SN; Lichtinger A; Kim P; Amiran MD; Slomovic AR Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]